Clinical Trial Update: Intermittent Naltrexone Among Polysubstance Users [Phase 2]

View source ↗

Summary

Phase 2 trial updating intermittent naltrexone use in polysubstance users with methamphetamine and alcohol use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Methamphetamine Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Methamphetamine, Alcohol | Phase 2 | Status: COMPLETED | Results posted: 2019-02-12